TRANSCENTA HOLDING - A global Fully Integrated Biotherapeutics Company
Transcenta, biologics, antibody
01 Nov, 2019
It’s official: President Donald Trump has nominated Stephen Hahn as the next commissioner of the FDA.
He will take over from Ned Sharpless, who had been running the U.S. regulator on an interim basis since Scott Gottlieb, another Trump pick, left in the spring. Sharpless had been a front-runner, but Hahn in the past few weeks had overtaken him.
In fact, Sharpless is making the unusual move of going straight back to his former role at the National Cancer Institute (NCI).